ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,37%
Bitcoin
66 010,19
-1,12%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Silo Pharma Inc (QB) (SILO)

  7. Silo Pharma Inc (QB) (SILO) Actualités

SILO

Silo Pharma (QB) (SILO)

Silo Pharma Inc (QB)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:SILO
DateHeureSourceTitreSymboleSociété
29/06/202322h32Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
26/05/202322h20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SILOSilo Pharma Inc (QB)
14/02/202322h01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:SILOSilo Pharma Inc (QB)
10/11/202222h49Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SILOSilo Pharma Inc (QB)
28/09/202222h35Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)USOTC:SILOSilo Pharma Inc (QB)
27/09/202214h30Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)USOTC:SILOSilo Pharma Inc (QB)
27/09/202212h03Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:SILOSilo Pharma Inc (QB)
26/09/202222h01Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)USOTC:SILOSilo Pharma Inc (QB)
09/09/202212h01Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SILOSilo Pharma Inc (QB)
07/03/202223h26Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:SILOSilo Pharma Inc (QB)
14/02/202223h43Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:SILOSilo Pharma Inc (QB)
06/01/202200h19Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:SILOSilo Pharma Inc (QB)
17/05/202113h40Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:SILOSilo Pharma Inc (QB)
13/04/202112h06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:SILOSilo Pharma Inc (QB)
25/02/202123h41Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:SILOSilo Pharma Inc (QB)
22/02/202122h28Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:SILOSilo Pharma Inc (QB)
16/02/202123h37Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:SILOSilo Pharma Inc (QB)
13/02/202100h19Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:SILOSilo Pharma Inc (QB)
10/02/202122h58Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:SILOSilo Pharma Inc (QB)
 Showing the most relevant articles for your search:USOTC:SILO

Dernières Valeurs Consultées

NASDAQ
AAPL
Apple
EU
LR
Legrand
SPI
SP500
S&P 500
COIN
ETHUSD
Ethereum
EU
MC
Lvmh Moet Hennessy Louis...
EU
GLE
Societe Generale
EU
PX1
CAC 40
USI
USTECH100
US Tech 100
EU
CAP
Capgemini
EU
BN
Danone
EU
DG
Vinci
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés